In an era where viral outbreaks can escalate into global pandemics with alarming speed, the ability to quickly develop new ...

An mRNA vaccine, a cousin to the COVID vaccines that blunted the pandemic, has entered human trials as a treatment for lung ...

A new vaccine provides hope for treating and even preventing the highly contagious and difficult-to-treat Clostridioides ...

The discovery of the first mRNA-stabilizing substance could pave the way for groundbreaking advancements in the development ...

However, the speed of vaccine production is limited because the mRNA used in it is partly chemically synthesized and partly ...

A year after the first samRNA vaccine approval, experts say others are likely to face scientific and regulatory hurdles.

Researchers are developing what they hope will be the first successful vaccine against the highly contagious and difficult-to ...

We recently published a list of 10 Best Depressed Stocks To Buy Heading into 2025. In this article, we are going to take a ...

On Thursday, Moderna Inc (MRNA) stock saw a decline, ending the day at $52.8 which represents a decrease of $-0.59 or -1.11% from the prior close of $53.39. The stock opened at $53.39 and touched a ...

An 800% increase in licensing deal values indicates growing confidence in mRNA technology, but some vaccine producers are ...

With exclusive FDA insight, the 4th mRNA Analytical Development & Quality Control Summit returns; uniting the Analytical, ...

Discover why the stock prices of mRNA therapy creators BioNTech and Moderna have plummeted and whether they are still worth ...